| Quantitative systems pharmacology modeling of PBMC-Humanized mouse to facilitate preclinical Immuno-oncology drug development H Ma, M Pilvankar, J Wang, C Giragossian, AS Popel ACS Pharmacology & Translational Science 4 (1), 213-225, 2020 | 14 | 2020 |
| Mathematical modeling of tuberculosis granuloma activation SM Ruggiero, MR Pilvankar, AN Ford Versypt Processes 5 (4), 79, 2017 | 13 | 2017 |
| Mathematical model for glucose dependence of the local renin–angiotensin system in podocytes MR Pilvankar, MA Higgins, AN Ford Versypt Bulletin of mathematical biology 80, 880-905, 2018 | 10 | 2018 |
| Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes C German, M Pilvankar, A Przekwas Journal of Pharmacokinetics and Pharmacodynamics 46 (6), 513-529, 2019 | 5 | 2019 |
| A glucose-dependent pharmacokinetic/pharmacodynamic model of ace inhibition in kidney cells MR Pilvankar, HL Yong, AN Ford Versypt Processes 7 (3), 131, 2019 | 4 | 2019 |
| Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager S Anbari, H Wang, Y Zhang, J Wang, M Pilvankar, M Nickaeen, S Hansel, ... Frontiers in Pharmacology 14, 1163432, 2023 | 3 | 2023 |
| Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies FHSK Kristina M.J. Aertker, Minu Ravindra Pilvankar, Tobias M. Prass ... mAbs 16 (1), 2024 | | 2024 |
| Human Dose and Pharmacokinetic Predictions for Biologics at Boehringer Ingelheim: A Retrospective Analysis R Grempler, J Ahlberg, E Germovsek, P Gupta, H Li, M Pilvankar, ... Advances in Therapy 41 (1), 364-378, 2024 | | 2024 |
| Intercellular Biochemical Cross-Talk at the Onset of Diabetic Kidney Disease MR Pilvankar, AD Sartin, C Streeter, SM Ruggiero, AF Versypt 2019 AIChE Annual Meeting, 2019 | | 2019 |
| Multiscale Computational Modeling of Renal Intercellular Cross-Talk at the Onset of Diabetic Kidney Disease MR Pilvankar, SM Ruggiero, AD Bucher, AF Versypt 2018 AIChE Annual Meeting, 2018 | | 2018 |
| Modeling Pharmaceutical Inhibition of Glucose-Stimulated Renin-Angiotensin System in Kidneys AN Ford Versypt, MR Pilvankar, HL Yong | | 2018 |
| A PK/PD Model of ACE Inhibition in Kidney Cells for Treatment of Diabetic Tissue Damage MR Pilvankar, HL Yong, AF Versypt 2017 AIChE Annual Meeting, 2017 | | 2017 |
| Supplementary Material Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager S Anbari, H Wang, Y Zhang, J Wang, M Pilvankar, M Nickaeen, S Hansel, ... | | |
| Modeling Pharmaceutical Inhibition of Glucose-Stimulated Renin-Angiotensin System in Kidneys ANF Versypt, MR Pilvankar, HL Yong | | |
Ashlee N. Ford VersyptAssociate Professor, Department of Chemical & Biological Engineering, University at Buffalo, SUNYDirección de correo verificada de buffalo.edu
